20 results
Diagnostic Algorithm for Treatment of Iron Deficiency in Patients With Heart Failure 

Consensus Recommendations 

#Iron #Deficiency
Diagnostic Algorithm ... for Treatment of ... Iron Deficiency ... Recommendations #Iron ... #HFrEF #sCHF #HeartFailure
Iron Deficiency in Heart Failure - Diagnosis and Treatment Algorithm
Diagnosis: Ferritin <100 ng/mL (absolute ID) OR
Diagnosis and Treatment ... Algorithm Diagnosis ... deficiency #CHF #HFrEF #heartfailure ... diagnosis #management #algorithm ... #cardiology #treatment
Algorithm for screening/diagnosis and treatment/follow‐up of iron deficiency in patients with chronic heart failure. Hb, haemoglobin;
Algorithm for screening ... /follow‐up of iron ... #HFrEF #sCHF #HeartFailure ... #Cardiology #Indications ... #Treatment
Iron Deficiency in Heart Failure
Pathophysiology:
Chronic heart failure leads to an increase in inflammatory cytokines → Inflammation
Ferritin <100 ng/mL ... Ferritin 100-299 ng/mL ... functional ID) Treatment ... deficiency #CHF #HFrEF #heartfailure ... diagnosis #management #cardiology
Iron Deficiency in Congestive Heart Failure (CHF)

Iron deficiency (ID) in heart failure is a common comorbidity
Ferritin < 100 ng/mL ... Ferritin 100 - 299 ng/mL ... ] Treatment Options ... #Failure #CHF #pharmacology ... pathophysiology #cardiology
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure: A
American College of Cardiology ... America #HFrEF #HeartFailure ... guideline #ACCAHA2017 #cardiology ... #treatment #algorithm
The goals of #COPD #treatment include recognizing the impact that both #symptoms and #exacerbations have on
The goals of #COPD ... #treatment include ... for monitoring treatment ... #management #algorithm ... #pharmacology
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... pulmonary disease (COPD ... #COPD #Treatment ... #Algorithm #Management ... SABA #SAMA #ICS #Pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
Reduce risk of COPD ... 100 Dosing: 250 mcg ... increase to 500 mcg ... recommendations for the treatment ... #Indications #Pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... Management #Pulmonary #COPD